Jing Hu
Southeast University(CN)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, RNA modifications and cancer, Ubiquitin and proteasome pathways, PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia(2015)183 cited
- → Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases(2023)169 cited
- → Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells(2015)147 cited
- → Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL(2016)141 cited
- → Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE2/β-catenin signalling pathway(2017)129 cited
- → TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway(2018)102 cited
- → Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution(2023)101 cited
- → Multiplex detection of tumor markers with photonic suspension array(2008)78 cited
- → Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer(2012)71 cited
- → TRIM44 promotes proliferation and metastasis in non-small cell lung cancer via mTOR signaling pathway(2016)64 cited